Dean Y Li - Net Worth and Insider Trading

Dean Y Li Net Worth

The estimated net worth of Dean Y Li is at least $31 Million dollars as of 2024-04-26. Dean Y Li is the Director of Recursion Pharmaceuticals Inc and owns about 3,170,666 shares of Recursion Pharmaceuticals Inc (RXRX) stock worth over $25 Million. Dean Y Li is also the Executive VP & President, MRL of Merck & Co Inc and owns about 46,242 shares of Merck & Co Inc (MRK) stock worth over $6 Million. Details can be seen in Dean Y Li's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dean Y Li has not made any transactions after 2024-02-09 and currently still holds the listed stock(s).

Transaction Summary of Dean Y Li

To

Dean Y Li Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dean Y Li owns 3 companies in total, including Merck & Co Inc (MRK) , Recursion Pharmaceuticals Inc (RXRX) , and Merck & Co Inc (MRKPRB.PFD) .

Click here to see the complete history of Dean Y Li’s form 4 insider trades.

Insider Ownership Summary of Dean Y Li

Ticker Comapny Transaction Date Type of Owner
MRK Merck & Co Inc 2024-02-09 Executive VP & President & MRL
RXRX Recursion Pharmaceuticals Inc 2024-01-09 director
MRKPRB.PFD Merck & Co Inc 2021-01-01 Executive VP & President & MRL

Dean Y Li Latest Holdings Summary

Dean Y Li currently owns a total of 2 stocks. Among these stocks, Dean Y Li owns 3,170,666 shares of Recursion Pharmaceuticals Inc (RXRX) as of January 9, 2024, with a value of $25 Million and a weighting of 80.44%. Dean Y Li also owns 46,242 shares of Merck & Co Inc (MRK) as of February 9, 2024, with a value of $6 Million and a weighting of 19.56%.

Latest Holdings of Dean Y Li

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RXRX Recursion Pharmaceuticals Inc 2024-01-09 3,170,666 7.84 24,858,021
MRK Merck & Co Inc 2024-02-09 46,242 130.72 6,044,754

Holding Weightings of Dean Y Li


Dean Y Li Form 4 Trading Tracker

According to the SEC Form 4 filings, Dean Y Li has made a total of 4 transactions in Recursion Pharmaceuticals Inc (RXRX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Recursion Pharmaceuticals Inc is the sale of 29,000 shares on January 9, 2024, which brought Dean Y Li around $396,140.

According to the SEC Form 4 filings, Dean Y Li has made a total of 1 transactions in Merck & Co Inc (MRK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Merck & Co Inc is the sale of 14,702 shares on February 9, 2024, which brought Dean Y Li around $2 Million.

Insider Trading History of Dean Y Li

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dean Y Li Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dean Y Li Ownership Network

Ownership Network List of Dean Y Li

No Data

Ownership Network Relation of Dean Y Li


Dean Y Li Owned Company Details

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Dean Y Li is the Executive VP & President & MRL of Merck & Co Inc. Other key executives at Merck & Co Inc include Evp & Global Svcs & CFO Robert M Davis , EVP & CFO Caroline Litchfield , and President & Human Health Int?l Joseph Romanelli .

Merck & Co Inc (MRK) Insider Trades Summary

Over the past 18 months, Dean Y Li made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 133,401 shares made by Steven Mizell , a net sale of 72,029 shares made by Johannes Jacobus Oosthuizen , and a net sale of 5,715 shares made by Joseph Romanelli .

In summary, during the past 3 months, insiders sold 309,424 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 309,424 shares. During the past 18 months, 3,968,347 shares of Merck & Co Inc (MRK) were sold and 409 shares were bought by its insiders, resulting in a net sale of 3,967,938 shares.

Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Merck & Co Inc Insider Transactions

No Available Data

Dean Y Li Mailing Address

Above is the net worth, insider trading, and ownership report for Dean Y Li. You might contact Dean Y Li via mailing address: 2000 Galloping Hill Road, Kenilworth Nj 07033.

Discussions on Dean Y Li

No discussions yet.